We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00498836
Recruitment Status : Completed
First Posted : July 10, 2007
Last Update Posted : September 12, 2013
Information provided by (Responsible Party):
Clavis Pharma

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : October 2008
  Study Completion Date : October 2008
  Certification or Request for Extension to Delay Results Submission: August 28, 2013